Edition:
India

People: Adamas Pharmaceuticals Inc (ADMS.OQ)

ADMS.OQ on NASDAQ Stock Exchange Global Market

3.04USD
30 Oct 2020
Change (% chg)

$-0.24 (-7.32%)
Prev Close
$3.28
Open
$3.27
Day's High
$3.31
Day's Low
$2.96
Volume
45,846
Avg. Vol
116,668
52-wk High
$7.44
52-wk Low
$1.90

Mahoney, David 

Mr. David L. Mahoney serves as Lead Independent Chairman of the Board of the Company. Mr. Mahoney has served on the board of directors of Symantec Corporation, a publicly-traded software technology company since 2003, including as current chair of the Compensation and as former chair of the Nominating and Governance Committees. Mr. Mahoney also served as a member of the Audit Committee of Symantec from 2003 to 2011. Mr. Mahoney has served on the board of directors of Corcept Therapeutics Incorporated, a pharmaceutical company since 2004, including as a member of the Audit and as a chair of the Nominating and Governance Committees. He also serves on the boards of directors of San Francisco Museum of Modern Art, Mount Holyoke College and Mercy Corps, and is a Trustee of the Schwab/Laudus Family of Funds. From 1999 to 2001, Mr. Mahoney served as co-CEO of McKesson HBOC, Inc., a healthcare supply management and information technology company and as CEO of McKesson LLC, a healthcare management and connectivity company. He joined McKesson Corporation in 1990 as Vice President for Strategic Planning. Prior to joining McKesson, Mr. Mahoney was a principal with McKinsey & Company, a management consulting firm, where he worked from 1981 to 1990. Mr. Mahoney holds a B.A. from Princeton University and an M.B.A. from Harvard University. We believe Mr. Mahoney’s extensive experience in pharmaceutical distribution, fiscal management, and in operating and advising technology companies qualifies him to serve on our Board of Directors.

Basic Compensation

Total Annual Compensation, USD 90,875
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 174,001
Fiscal Year Total, USD 264,876

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Mahoney

264,876

Neil McFarlane

2,080,640

Christopher Prentiss

1,093,640

Adrian Quartel

--

Vijay Shreedhar

1,230,090

John MacPhee

67,705
As Of  31 Dec 2019